From Fermentation To Vaccination: Non Animal Origin Squalene For High-Risk Applications

As the global focus on sustainability and ethical sourcing intensifies, industries and consumers alike are seeking alternatives to traditional animal-derived ingredients. One such ingredient under scrutiny is squalene, a vital component in vaccine adjuvants known for its ability to enhance immune response. Historically, squalene has been extracted from shark liver oil—a method that poses serious environmental concerns, including overfishing and the decline of shark populations.

In response to these challenges, the development of non-animal-origin (NAO) squalene has emerged as a critical innovation. NAO Squalene Emprove® Expert offers a compelling solution that provides a sustainable and ethically sourced alternative without compromising on quality or performance. This application note presents robust data demonstrating the purity and stability of NAO Squalene, both as a raw material and within nanoemulsion formulations. Remarkably, the nanoemulsion formulation shows identical stability and efficacy whether it incorporates shark-derived or NAO squalene, reinforcing the viability of this alternative.

As the demand for responsibly sourced ingredients continues to grow, adopting NAO Squalene is not just a choice—it's a commitment to environmental stewardship and ethical innovation. Explore the full potential of NAO Squalene Emprove® Expert and join the movement toward sustainable solutions in pharmaceutical development.